glp-1 stock price Moby | The wars are heating up. Novo Nordisk (NVO) is suing rival Eli Lilly (LLY), alleging the drugmaker used outdated clinical trial data GLP-1 Receptor Agonist Market Growth
Pay in 4 interest-free payments of $6.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11























